• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Intraoperative Parathyroid Hormone Monitoring Criteria in Primary Hyperparathyroidism: A Network Meta-Analysis of Diagnostic Test Accuracy.原发性甲状旁腺功能亢进症术中甲状旁腺激素监测标准:诊断试验准确性的网状Meta分析
JAMA Otolaryngol Head Neck Surg. 2025 Mar 1;151(3):190-200. doi: 10.1001/jamaoto.2024.4453.
2
[Evaluation of different intraoperative iPTH assay criteria in monitoring of minimally invasive parathyroidectomy for primary hyperparathyroidism].[不同术中甲状旁腺激素检测标准在原发性甲状旁腺功能亢进症微创甲状旁腺切除术中监测的评估]
Przegl Lek. 2014;71(1):14-8.
3
Use of Intraoperative Parathyroid Hormone in Minimally Invasive Parathyroidectomy for Primary Hyperparathyroidism: A Systematic Review and Meta-analysis.原发性甲状旁腺功能亢进症微创甲状旁腺切除术应用术中甲状旁腺激素检测的系统评价和荟萃分析。
JAMA Otolaryngol Head Neck Surg. 2021 Feb 1;147(2):135-143. doi: 10.1001/jamaoto.2020.4021.
4
Minimally invasive parathyroidectomy guided by intraoperative parathyroid hormone monitoring (IOPTH) and preoperative imaging versus bilateral neck exploration for primary hyperparathyroidism in adults.术中甲状旁腺激素监测(IOPTH)和术前影像学引导下的微创甲状旁腺切除术与双侧颈部探查治疗成人原发性甲状旁腺功能亢进症的比较
Cochrane Database Syst Rev. 2020 Oct 21;10(10):CD010787. doi: 10.1002/14651858.CD010787.pub2.
5
Utility of intraoperative parathyroid hormone monitoring in patients with multiple endocrine neoplasia type 1-associated primary hyperparathyroidism undergoing initial parathyroidectomy.术中甲状旁腺激素监测在 1 型多发性内分泌腺瘤相关原发性甲状旁腺功能亢进症患者行初次甲状旁腺切除术的应用。
World J Surg. 2013 Aug;37(8):1966-72. doi: 10.1007/s00268-013-2054-1.
6
Effectiveness of Intraoperative Parathyroid Monitoring (ioPTH) in predicting a multiglandular or malignant parathyroid disease.术中甲状旁腺监测(ioPTH)预测多腺体或恶性甲状旁腺疾病的有效性。
Int J Surg. 2017 May;41 Suppl 1:S26-S33. doi: 10.1016/j.ijsu.2017.02.063.
7
The role of Rapid Intraoperative Parathyroid Hormone (ioPTH) assay in determining outcome of parathyroidectomy in primary hyperparathyroidism: A systematic review and meta-analysis.甲状旁腺激素(ioPTH)快速检测在原发性甲状旁腺功能亢进症甲状旁腺切除术中的作用:系统评价和荟萃分析。
Int J Surg. 2021 Aug;92:106042. doi: 10.1016/j.ijsu.2021.106042. Epub 2021 Jul 30.
8
Intraoperative parathyroid hormone assay improves outcomes of minimally invasive parathyroidectomy mainly in patients with a presumed solitary parathyroid adenoma and missing concordance of preoperative imaging.术中甲状旁腺激素测定主要改善了术前影像学检查未发现一致性且疑似孤立性甲状旁腺腺瘤患者的微创甲状旁腺切除术的治疗效果。
Clin Endocrinol (Oxf). 2007 Jun;66(6):878-85. doi: 10.1111/j.1365-2265.2007.02827.x. Epub 2007 Apr 15.
9
Evaluation of Halle, Miami, Rome, and Vienna intraoperative iPTH assay criteria in guiding minimally invasive parathyroidectomy.评估哈雷、迈阿密、罗马和维也纳术中甲状旁腺激素(iPTH)检测标准在指导微创甲状旁腺切除术中的应用
Langenbecks Arch Surg. 2009 Sep;394(5):843-9. doi: 10.1007/s00423-009-0510-z. Epub 2009 Jun 16.
10
Investigating intraoperative parathyroid hormone criteria for enhanced accuracy and surgical success in treating primary hyperparathyroidism: results from two tertiary referral centres.探究术中甲状旁腺激素标准以提高原发性甲状旁腺功能亢进治疗的准确性和手术成功率:来自两个三级转诊中心的结果
BJS Open. 2025 May 7;9(3). doi: 10.1093/bjsopen/zraf055.

引用本文的文献

1
Impact of 18F-choline PET-CT or PET-MRI on surgical strategy in patients with primary hyperparathyroidism.18F-胆碱PET-CT或PET-MRI对原发性甲状旁腺功能亢进患者手术策略的影响
BJS Open. 2025 Jul 1;9(4). doi: 10.1093/bjsopen/zraf069.
2
Intraoperative parathyroid hormone monitoring to guide surgery in renal hyperparathyroidism (PEREGRINE): a protocol for a randomised multiarm surgical pilot trial.术中甲状旁腺激素监测指导肾性甲状旁腺功能亢进手术(PEREGRINE):一项随机多臂手术试点试验方案
BMJ Open. 2025 Jul 17;15(7):e098860. doi: 10.1136/bmjopen-2025-098860.
3
Do stricter criteria for intraoperative parathyroid hormone monitoring reduce the risk of persistence or reoperation in primary hyperparathyroidism? A receiver operating characteristic analysis.原发性甲状旁腺功能亢进症中,更严格的术中甲状旁腺激素监测标准能否降低持续性甲状旁腺功能亢进或再次手术的风险?一项受试者工作特征分析。
Langenbecks Arch Surg. 2025 Jul 10;410(1):220. doi: 10.1007/s00423-025-03796-4.
4
Errors in Table and Figures.表格和图表中的错误。
JAMA Otolaryngol Head Neck Surg. 2025 Mar 1;151(3):285. doi: 10.1001/jamaoto.2025.0010.

本文引用的文献

1
Intraoperative parathyroid hormone assay benefits surgery for primary hyperparathyroidism when preoperative localisation is negative or not performed.当术前定位检查结果为阴性或未进行术前定位检查时,术中甲状旁腺激素测定对原发性甲状旁腺功能亢进症手术有益。
Ann R Coll Surg Engl. 2024 Sep 25. doi: 10.1308/rcsann.2024.0051.
2
Intraoperative parathyroid hormone monitoring in parathyroidectomy for hyperparathyroidism: a protocol for a network meta-analysis of diagnostic test accuracy.甲状旁腺功能亢进症甲状旁腺切除术中的术中甲状旁腺激素监测:诊断试验准确性网络荟萃分析方案
Front Surg. 2024 Jan 4;10:1298611. doi: 10.3389/fsurg.2023.1298611. eCollection 2023.
3
Update on the current management of persistent and recurrent primary hyperparathyroidism after parathyroidectomy.甲状旁腺切除术后持续性和复发性原发性甲状旁腺功能亢进症的当前管理进展
World J Clin Cases. 2023 Apr 6;11(10):2213-2225. doi: 10.12998/wjcc.v11.i10.2213.
4
A 15-year experience: intraoperative parathyroid hormone assay for the management of primary hyperparathyroidism in a UK endocrine surgical unit.15 年经验:英国内分泌外科单位中甲状旁腺激素检测在原发性甲状旁腺功能亢进症管理中的应用。
Langenbecks Arch Surg. 2023 Mar 15;408(1):120. doi: 10.1007/s00423-023-02848-x.
5
The value of intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism and varying baseline parathyroid hormone levels.原发性甲状旁腺功能亢进症患者术中甲状旁腺激素监测的价值及其基础甲状旁腺激素水平变化。
BJS Open. 2022 Nov 2;6(6). doi: 10.1093/bjsopen/zrac118.
6
Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop.原发性甲状旁腺功能亢进的评估与管理:第五次国际研讨会总结声明和指南。
J Bone Miner Res. 2022 Nov;37(11):2293-2314. doi: 10.1002/jbmr.4677. Epub 2022 Oct 17.
7
Primary Hyperparathyroidism and Intraoperative Parathyroid Hormone Monitoring: Application of a Modified Interpretation in Patients With "Parathyroid Hormone Spikes".原发性甲状旁腺功能亢进症和术中甲状旁腺激素监测:“甲状旁腺激素飙升”患者中改良解读的应用。
J Surg Res. 2023 Feb;282:9-14. doi: 10.1016/j.jss.2022.08.016. Epub 2022 Oct 13.
8
Contribution of intraoperative parathyroid hormone monitoring to the surgical success in minimal invasive parathyroidectomy.术中甲状旁腺激素监测对微创甲状旁腺切除术手术成功的贡献。
Front Surg. 2022 Sep 21;9:1024350. doi: 10.3389/fsurg.2022.1024350. eCollection 2022.
9
Interpretation of intraoperative parathyroid hormone monitoring according to the Rome criterion in primary hyperparathyroidism.根据罗马标准解读原发性甲状旁腺功能亢进症术中甲状旁腺激素监测。
Sci Rep. 2022 Feb 28;12(1):3333. doi: 10.1038/s41598-022-07380-4.
10
Diagnostic test accuracy network meta-analysis methods: A scoping review and empirical assessment.诊断测试准确性网络荟萃分析方法:范围综述和实证评估。
J Clin Epidemiol. 2022 Jun;146:86-96. doi: 10.1016/j.jclinepi.2022.02.001. Epub 2022 Feb 16.

原发性甲状旁腺功能亢进症术中甲状旁腺激素监测标准:诊断试验准确性的网状Meta分析

Intraoperative Parathyroid Hormone Monitoring Criteria in Primary Hyperparathyroidism: A Network Meta-Analysis of Diagnostic Test Accuracy.

作者信息

Staibano Phillip, Au Michael, Zhang Han, Yu Sheila, Liu Winnie, Pasternak Jesse D, Xing Xing, Seib Carolyn D, Orloff Lisa, Nguyen Nhu-Tram, Gupta Michael K, Monteiro Eric, Parpia Sameer, McKechnie Tyler, Thabane Alex, Young J E M Ted, Bhandari Mohit

机构信息

Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada.

Department of Health Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.

出版信息

JAMA Otolaryngol Head Neck Surg. 2025 Mar 1;151(3):190-200. doi: 10.1001/jamaoto.2024.4453.

DOI:10.1001/jamaoto.2024.4453
PMID:39724136
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11907319/
Abstract

IMPORTANCE

Intraoperative parathyroid hormone (IOPTH) monitoring is recommended by the American Association of Endocrine Surgeons for use during parathyroidectomy for patients with primary hyperparathyroidism (PHPT), but there is no clinician consensus regarding the IOPTH monitoring criteria that optimize diagnostic accuracy.

OBJECTIVE

To evaluate and rank the diagnostic properties of IOPTH monitoring criteria used during surgery for patients with PHPT.

DATA SOURCES

A bayesian diagnostic test accuracy network meta-analysis (DTA-NMA) was performed, in which peer-reviewed citations from January 1, 1990, to July 22, 2023, were searched for in MEDLINE, Embase, Web of Science, CENTRAL, and CINAHL.

STUDY SELECTION

All full-text study designs that evaluated any IOPTH monitoring criteria as a diagnostic test were included in this meta-analysis. Any studies evaluating adult patients diagnosed with PHPT undergoing parathyroidectomy were also included. The reference standard used in this study was normalization of calcium and/or parathyroid hormone levels within 1 year of surgery.

DATA EXTRACTION AND SYNTHESIS

This DTA-NMA was reported in accordance with the applicable Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guidelines. Two reviewers evaluated all abstracts and full-text articles using a piloted extraction form. A third author resolved any conflicts. There are no published Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) resources for DTA-NMA. The following conventional monitoring criteria were included: Halle, Miami, Rome, Vienna, and PTH normalization, and the following modified criteria were included: Miami and PTH normalization, modified Miami, and modified Vienna. A bayesian hierarchical DTA-NMA model with corresponding 95% credible intervals (CrIs) was used to describe the pooled diagnostic characteristics of the evaluated IOPTH monitoring criteria.

MAIN OUTCOMES AND MEASURES

Main outcomes included pooled diagnostic test properties, including sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio.

RESULTS

A total of 72 studies, which included 19 072 patients, met the inclusion criteria. Sixty-nine studies (95.8%) investigated classic PHPT. In PHPT, the Miami criteria were investigated most often and had the best diagnostic properties (diagnostic odds ratio, 60.00 [95% CrI, 32.00-145.00]) when compared to other conventional criteria. Moreover, the modified Miami criteria, which measures a postexcision IOPTH level 15 minutes or more postexcision of all hyperfunctioning parathyroid tissue, were the overall best criteria (diagnostic odds ratio, 79.71 [95% CrI, 22.46-816.67]). There was a low risk of study bias and no publication bias.

CONCLUSIONS AND RELEVANCE

The results of this meta-analysis suggest that surgeons should use the modified Miami criteria when performing IOPTH-guided surgery for patients with PHPT because these criteria optimize intraoperative diagnostic accuracy by minimizing unnecessary neck exploration and revision surgery rates.

摘要

重要性

美国内分泌外科医师协会推荐在原发性甲状旁腺功能亢进症(PHPT)患者的甲状旁腺切除术中使用术中甲状旁腺激素(IOPTH)监测,但对于优化诊断准确性的IOPTH监测标准,临床医生尚无共识。

目的

评估并对PHPT患者手术期间使用的IOPTH监测标准的诊断特性进行排名。

数据来源

进行了一项贝叶斯诊断试验准确性网络荟萃分析(DTA-NMA),在MEDLINE、Embase、科学网、CENTRAL和护理学与健康领域数据库中搜索了1990年1月1日至2023年7月22日的同行评审文献。

研究选择

所有将任何IOPTH监测标准作为诊断试验进行评估的全文研究设计均纳入本荟萃分析。任何评估诊断为PHPT的成年患者接受甲状旁腺切除术的研究也包括在内。本研究使用的参考标准是术后1年内钙和/或甲状旁腺激素水平正常化。

数据提取与合成

本DTA-NMA按照适用的系统评价和荟萃分析首选报告项目(PRISMA)报告指南进行报告。两名评审员使用预先设计的提取表评估所有摘要和全文文章。第三位作者解决任何冲突。目前尚无已发表的关于DTA-NMA的推荐分级、评估、制定和评价(GRADE)资源。纳入了以下传统监测标准:哈雷标准、迈阿密标准、罗马标准、维也纳标准和甲状旁腺激素正常化标准,还纳入了以下改良标准:迈阿密标准和甲状旁腺激素正常化标准、改良迈阿密标准和改良维也纳标准。使用具有相应95%可信区间(CrIs)的贝叶斯分层DTA-NMA模型来描述所评估的IOPTH监测标准的汇总诊断特征。

主要结局和指标

主要结局包括汇总诊断试验特性,包括敏感性、特异性、阳性似然比、阴性似然比和诊断比值比。

结果

共有72项研究,包括19072例患者,符合纳入标准。69项研究(95.8%)调查了经典PHPT。在PHPT中,迈阿密标准研究得最多,与其他传统标准相比,具有最佳诊断特性(诊断比值比,60.00 [95% CrI,32.00 - 145.00])。此外,改良迈阿密标准,即测量所有功能亢进甲状旁腺组织切除术后15分钟或更长时间的术后IOPTH水平,是总体最佳标准(诊断比值比,79.71 [95% CrI,22.46 - 816.67])。研究偏倚风险较低,且无发表偏倚。

结论与意义

本荟萃分析结果表明,外科医生在为PHPT患者进行IOPTH引导的手术时应使用改良迈阿密标准,因为这些标准通过最大限度减少不必要的颈部探查和翻修手术率来优化术中诊断准确性。